KUKJEON PHARMACEUTICAL Co.,Ltd Logo

KUKJEON PHARMACEUTICAL Co.,Ltd

A chemical solutions provider manufacturing Active Pharmaceutical Ingredients and electronic materials.

307750 | KO

Overview

Corporate Details

ISIN(s):
KR7307750000
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 학의로 282 B동 1516호 (관양동,금강펜테리움), 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the manufacture and sale of Active Pharmaceutical Ingredients (APIs) and electronic materials. With approximately 50 years of operational experience, the company has established itself as an API specialist. Its primary business involves producing and supplying raw materials for specialized medicines, including choline alfoscerates, benfothiamines, spherical sorbents, and napamostat. In addition to its pharmaceutical operations, the company develops electronic materials. Kukjeon also offers services such as molecular design and technical support, aiming to provide a comprehensive range of chemical-based products and services to its customers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 12.2 KB
2025-09-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.8 KB
2025-08-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.7 KB
2025-08-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 134.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-06 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.7 KB
2025-07-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 133.1 KB
2025-07-07 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 135.0 KB
2025-06-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 143.5 KB
2025-06-16 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.7 KB
2025-06-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 139.7 KB
2025-06-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 138.9 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-05-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 135.2 KB
2025-04-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 136.4 KB

Automate Your Workflow. Get a real-time feed of all KUKJEON PHARMACEUTICAL Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KUKJEON PHARMACEUTICAL Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KUKJEON PHARMACEUTICAL Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BOIRON Logo
Global manufacturer of homeopathic medicines for pain relief and flu-like symptoms, sold worldwide.
France
BOI
Bon Natural Life Ltd Logo
Bio-manufactures natural plant ingredients for fragrances, supplements, and immunity solutions.
United States of America
BON
Bosnalijek d.d. Sarajevo Logo
Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.
Bosnia and Herzegovina
BSNL
Boundless Bio, Inc. Logo
Developing ecDNA-directed therapies for intractable oncogene amplified cancers.
United States of America
BOLD
BridgeBio Oncology Therapeutics, Inc. Logo
Clinical-stage biopharma creating small molecule drugs for RAS-dependent cancers.
United States of America
BBOT
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and genetically driven cancers.
United States of America
BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Developing next-gen serotonergic drugs for neurological and psychiatric disorders like epilepsy.
United States of America
DRUG
BRISTOL MYERS SQUIBB CO Logo
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
United States of America
BMY
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea
003000
Burning Rock Biotech Ltd Logo
Offers NGS-based diagnostics for precision oncology, from detection to clinical trial support.
United States of America
BNR

Talk to a Data Expert

Have a question? We'll get back to you promptly.